{"transactions":[{"id":4340928,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":176643,"kind":"person","name":"CRAIG THOMAS","position":1,"cik":"0001184156","reported_name":"CRAIG THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-01T22:02:19.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":43,"price":167.73,"value":7212.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($7,143.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":24471,"source":{"system":"sec-edgar","filing":"0001140361-17-017676","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117017676/doc1.xml","form_type":"4"}},{"id":4476002,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":176643,"kind":"person","name":"CRAIG THOMAS","position":1,"cik":"0001184156","reported_name":"CRAIG THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T22:06:35.000Z","date":"2017-01-30","kind":"grant","acquired":true,"shares":145,"price":120.5,"value":17472.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($17,500.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":24428,"source":{"system":"sec-edgar","filing":"0001140361-17-003774","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036117003774/doc1.xml","form_type":"4"}},{"id":4541549,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":176643,"kind":"person","name":"CRAIG THOMAS","position":1,"cik":"0001184156","reported_name":"CRAIG THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2016-11-29T00:33:23.000Z","date":"2016-11-23","kind":"exercise","acquired":false,"shares":9924,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,962 shares on February 14, 2011, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the \"Stock Split\").? The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split."}],"balance_after":0,"derivative":{"exercise_price":26.655,"expiration_date":"2017-02-13","underlying":"Common Stock","underlying_shares":9924},"source":{"system":"sec-edgar","filing":"0001140361-16-087991","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036116087991/doc1.xml","form_type":"4"}},{"id":4541548,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":176643,"kind":"person","name":"CRAIG THOMAS","position":1,"cik":"0001184156","reported_name":"CRAIG THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-29T00:33:23.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":8500,"price":120.061,"value":1020518.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price of the shares sold ranging from a low of $119.5082 to a high of $120.23 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price."}],"balance_after":24283,"source":{"system":"sec-edgar","filing":"0001140361-16-087991","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036116087991/doc1.xml","form_type":"4"}},{"id":4541547,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":176643,"kind":"person","name":"CRAIG THOMAS","position":1,"cik":"0001184156","reported_name":"CRAIG THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-29T00:33:23.000Z","date":"2016-11-23","kind":"exercise","acquired":true,"shares":9924,"price":26.655,"value":264524.22,"ownership":{"direct":true},"balance_after":32783,"source":{"system":"sec-edgar","filing":"0001140361-16-087991","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036116087991/doc1.xml","form_type":"4"}},{"id":4572408,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":176643,"kind":"person","name":"CRAIG THOMAS","position":1,"cik":"0001184156","reported_name":"CRAIG THOMAS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-31T22:29:02.000Z","date":"2016-10-28","kind":"grant","acquired":true,"shares":167,"price":105.05,"value":17543.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the \"Plan\") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($17,500.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan."}],"balance_after":22859,"source":{"system":"sec-edgar","filing":"0001140361-16-084224","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000114036116084224/doc1.xml","form_type":"4"}}]}